Abiopharma

🔍 Fejes Balazs (Director)

Company: EPAM Systems, Inc. (EPAM)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 412 shares of EPAM Common Stock at $117.83 per share (Direct)
  Date: 2026-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 48,279.64 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares were withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted stock units granted to the reporting person under the Issuer's Long Term Incentive Plan. This disposition is exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3(e), as shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of the underlying award, which was approved in advance by the Issuer's Board of Directors.